Amgen Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Amgen Inc. (AMGN) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 0 shares for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2015-02-19
- Amgen Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2013-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- Amgen Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2013-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- Amgen Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2012-09-30 was 1.00M shares, a 96.97% decline year-over-year.
- Amgen Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2012-06-30 was 10.00M shares, a 67.74% decline year-over-year.
- Amgen Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2012 was 6.00M shares, a 81.82% decline from fiscal 2011.
- Amgen Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2011 was 33.00M shares, a 23.26% decline from fiscal 2010.
- Amgen Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2010 was 43.00M shares, a 2.38% increase from fiscal 2009.
- Amgen Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2009 was 42.00M shares, a 6.67% decline from fiscal 2008.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2013-06-30 | 0.00 shares 10-Q · filed 2013-08-06 | 0.00 shares 10-Q · filed 2013-08-06 | ||
| 2013-03-31 | 0.00 shares 10-Q · filed 2013-05-03 | |||
| 2012-12-31 | 6.00M shares 10-K · filed 2015-02-19 | |||
| 2012-09-30 | 1.00M shares 10-Q · filed 2013-10-29 | 8.00M shares 10-Q · filed 2013-10-29 | ||
| 2012-06-30 | 10.00M shares 10-Q · filed 2013-08-06 | 11.00M shares 10-Q · filed 2013-08-06 | ||
| 2012-03-31 | 11.00M shares 10-Q · filed 2013-05-03 | |||
| 2011-12-31 | 33.00M shares 10-K · filed 2014-02-24 | |||
| 2011-09-30 | 33.00M shares 10-Q · filed 2012-11-06 | 34.00M shares 10-Q · filed 2012-11-06 | ||
| 2011-06-30 | 31.00M shares 10-Q · filed 2012-08-08 | 35.00M shares 10-Q · filed 2012-08-08 | ||
| 2011-03-31 | 39.00M shares 10-Q · filed 2012-05-08 | |||
| 2010-12-31 | 43.00M shares 10-K · filed 2013-02-27 | |||
| 2010-09-30 | 44.00M shares 10-Q · filed 2011-11-04 | 44.00M shares 10-Q · filed 2011-11-04 | ||
| 2010-06-30 | 46.00M shares 10-Q · filed 2011-08-08 | 43.00M shares 10-Q · filed 2011-08-08 | ||
| 2010-03-31 | 40.00M shares 10-Q · filed 2011-05-10 | |||
| 2009-12-31 | 42.00M shares 10-K · filed 2012-02-29 | |||
| 2009-09-30 | 31.00M shares 10-Q · filed 2010-11-08 | 43.00M shares 10-Q · filed 2010-11-08 | ||
| 2009-06-30 | 51.00M shares 10-Q · filed 2010-08-09 | 48.00M shares 10-Q · filed 2010-08-09 | ||
| 2008-12-31 | 45.00M shares 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |